Osivax

This study tests a single dose of a new flu vaccine called OVX836 in about 2,850 healthy adults aged 18 to 59. The goal is to see if it can prevent confirmed influenza A and is safe. Participants receive either the vaccine or a placebo shot, and researchers track flu cases over t…